Research Article: A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD
Abstract:
Graphical Abstract:
Introduction:
Systemic (oral or parenteral) corticosteroids are increasingly used by patients with chronic obstructive pulmonary disease (COPD). Findings presented at the British Thoracic Society Winter Meeting demonstrated that COPD was the second-leading contributor to total systemic corticosteroid dose among conditions of interest in the UK, and systemic corticosteroid prescriptions in patients with COPD increased from .% in to .% in . In , a UK study reported that % of patients with COPD were prescribed oral corticosteroids…
Read more